Importance Preeclampsia is a hypertensive disorder of pregnancy that poses serious
maternal and infant health risks. Previous systematic reviews have established benefits of …

Background Preeclampsia and fetal growth restriction are major causes of perinatal death
and handicap in survivors. Randomized clinical trials have reported that the risk of …

Background: Preeclampsia is a leading cause of maternal and perinatal morbidity and
mortality. Purpose: To systematically review benefits and harms of low-dose aspirin for …

Background The optimum time for commencing antiplatelet therapy for the prevention of
preeclampsia and its complications is unclear. Aggregate data meta-analyses suggest that …

OBJECTIVE: To estimate the effect of low-dose aspirin started in early pregnancy on the
incidence of preeclampsia and intrauterine growth restriction (IUGR). DATA SOURCES: A …

This presentation of the diseases of the placenta differs in many ways from the first such
treatment in these volumes by the eminent Robert Meyer. It is a deliberate attempt to bring …

Objective To compare early vs late administration of low‐dose aspirin on the risk of perinatal
death and adverse perinatal outcome. Methods Databases were searched for keywords …

Background Pre‐eclampsia is associated with deficient intravascular production of
prostacyclin, a vasodilator, and excessive production of thromboxane, a vasoconstrictor and …

Background Pre-eclampsia is a major cause of mortality and morbidity during pregnancy
and childbirth. Antiplatelet agents, especially low-dose aspirin, might prevent or delay pre …

Hypertensive disorders affect as many as 10% of all pregnancies worldwide. 1 This
heterogeneous group of disorders includes chronic hypertension, gestational hypertension …